Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient

Abstract Background Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various Leishmania species, and transmitted by the sand-fly vectors, Phlebotomus and Lutzomyia species. Herein, we report for the first time a case of CL that presented as large eczematous pla...

Full description

Bibliographic Details
Main Authors: Hamida Al-Dwibe, Aisha Gashout, Abdu-Maged Morogum, Said El-Zubi, Ahmad Amro
Format: Article
Language:English
Published: BMC 2014-08-01
Series:Parasites & Vectors
Subjects:
Online Access:https://doi.org/10.1186/1756-3305-7-401
_version_ 1797811671142498304
author Hamida Al-Dwibe
Aisha Gashout
Abdu-Maged Morogum
Said El-Zubi
Ahmad Amro
author_facet Hamida Al-Dwibe
Aisha Gashout
Abdu-Maged Morogum
Said El-Zubi
Ahmad Amro
author_sort Hamida Al-Dwibe
collection DOAJ
description Abstract Background Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various Leishmania species, and transmitted by the sand-fly vectors, Phlebotomus and Lutzomyia species. Herein, we report for the first time a case of CL that presented as large eczematous plaques occurring on the dorsi of both feet in a Libyan drug addicted, alcoholic patient with HIV infection. Findings A 34 year-old HIV-positive, alcoholic, drug addicted Libyan male presented to us with a history of a non-itchy skin lesions on the dorsi of both feet of 5-weeks duration. Systemic and topical antibiotics were given without improvement. Diagnosis of this patient was confirmed by observation of Leishmania amastigote bodies in stained slit-skin smear skin biopsy. After parenteral administration of sodium stiboglyconate (Pentostam) (20 mg/kg/day) for 28 days the lesions did not show any marked improvement. Concurrently, combination therapy of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) was given for 8 weeks. Complete healing of lesions was achieved after this treatment and skin-slit smears turned negative. Conclusions Localized cutaneous leishmaniasis should be remembered in deferential diagnosis of unresponsive contact dermatitis especially for HIV-positive patients in CL endemic areas. This patient was not responding to Pentostam therapy, which is not very common in Libya. Interestingly, combination of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) can be a successful alternative therapy.
first_indexed 2024-03-13T07:27:09Z
format Article
id doaj.art-324ccdefcd7e40bc896f7c79043759b7
institution Directory Open Access Journal
issn 1756-3305
language English
last_indexed 2024-03-13T07:27:09Z
publishDate 2014-08-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj.art-324ccdefcd7e40bc896f7c79043759b72023-06-04T11:19:15ZengBMCParasites & Vectors1756-33052014-08-01711310.1186/1756-3305-7-401Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patientHamida Al-Dwibe0Aisha Gashout1Abdu-Maged Morogum2Said El-Zubi3Ahmad Amro4Faculty of Medicine, Dermatology Department, University of TripoliFaculty of Medical Technology-Pathology Department, University of TripoliFaculty of Medicine, Dermatology Department, University of TripoliFaculty of Medicine, Dermatology Department, University of TripoliFaculty of Pharmacy, Alquds UniversityAbstract Background Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various Leishmania species, and transmitted by the sand-fly vectors, Phlebotomus and Lutzomyia species. Herein, we report for the first time a case of CL that presented as large eczematous plaques occurring on the dorsi of both feet in a Libyan drug addicted, alcoholic patient with HIV infection. Findings A 34 year-old HIV-positive, alcoholic, drug addicted Libyan male presented to us with a history of a non-itchy skin lesions on the dorsi of both feet of 5-weeks duration. Systemic and topical antibiotics were given without improvement. Diagnosis of this patient was confirmed by observation of Leishmania amastigote bodies in stained slit-skin smear skin biopsy. After parenteral administration of sodium stiboglyconate (Pentostam) (20 mg/kg/day) for 28 days the lesions did not show any marked improvement. Concurrently, combination therapy of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) was given for 8 weeks. Complete healing of lesions was achieved after this treatment and skin-slit smears turned negative. Conclusions Localized cutaneous leishmaniasis should be remembered in deferential diagnosis of unresponsive contact dermatitis especially for HIV-positive patients in CL endemic areas. This patient was not responding to Pentostam therapy, which is not very common in Libya. Interestingly, combination of oral rifampicin (600 mg/day) and isoniazide (300 mg/day) can be a successful alternative therapy.https://doi.org/10.1186/1756-3305-7-401Cutaneous leishmaniasisContact dermatitisHIVSodium stiboglyconate (Pentostam)Libya
spellingShingle Hamida Al-Dwibe
Aisha Gashout
Abdu-Maged Morogum
Said El-Zubi
Ahmad Amro
Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
Parasites & Vectors
Cutaneous leishmaniasis
Contact dermatitis
HIV
Sodium stiboglyconate (Pentostam)
Libya
title Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
title_full Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
title_fullStr Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
title_full_unstemmed Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
title_short Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient
title_sort contact dermatitis like cutaneous leishmaniasis in a libyan hiv patient
topic Cutaneous leishmaniasis
Contact dermatitis
HIV
Sodium stiboglyconate (Pentostam)
Libya
url https://doi.org/10.1186/1756-3305-7-401
work_keys_str_mv AT hamidaaldwibe contactdermatitislikecutaneousleishmaniasisinalibyanhivpatient
AT aishagashout contactdermatitislikecutaneousleishmaniasisinalibyanhivpatient
AT abdumagedmorogum contactdermatitislikecutaneousleishmaniasisinalibyanhivpatient
AT saidelzubi contactdermatitislikecutaneousleishmaniasisinalibyanhivpatient
AT ahmadamro contactdermatitislikecutaneousleishmaniasisinalibyanhivpatient